SIM
MACK

SSI Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

SSI Investment Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-8,696
Closed -$365K – 449
2013
Q4 		$365K Buy
+8,696
New +$252K 0.03% 352

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSI Investment Management's MACK Position: Q1 2014 in Review

SSI Investment Management sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q1 2014, closing a stake of 8,696 shares — an estimated $365K sold.

SSI Investment Management first reported a position in MACK in Q4 2013 and held it in 1 quarter. The position peaked at $365K in Q4 2013. 102 funds tracked by Wall St. Rank hold MACK as of Q1 2014.

  • SSI Investment Management reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • SSI Investment Management sold 8,696 Merrimack Pharmaceuticals, Inc. shares in Q1 2014, an estimated $365K.
  • SSI Investment Management first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2013 and held it in 1 quarter.
  • SSI Investment Management's Merrimack Pharmaceuticals, Inc. position peaked at $365K in Q4 2013.
  • 102 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q1 2014.

Based on SSI Investment Management's 13F filing for Q1 2014, filed 9 May 2014.